Michael Carron, MD
Otolaryngology · Dearborn, MINPI 1568670156
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (57.0%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Microaire Surgical Instruments LLC accounts for 86.0% of it on its own, with 24 other manufacturers making up the rest. 2025 is the largest year on record at $13,853, 2.6 times the $5,382 reported in 2019. Among otolaryngology clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 102 payments — averaging $219.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Microaire Surgical Instruments LLC$19K
- Optinose US, Inc.$712
- Biotissue Holdings Inc.$466
- Medtronic$290
- Stryker$256
- Johnson & Johnson$252
- plus $1K from 19 others
What the payments were for
- Consulting fees$3,44015%
- Speaking & faculty fees$12,75057%
- Travel & lodging$3,08714%
- Food & beverage$3,07014%
- Education$160%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Microaire Surgical Instruments LLC | 11 | $19,243 |
| Optinose US, Inc. | 32 | $712 |
| Biotissue Holdings Inc. | 5 | $466 |
| Medtronic | 6 | $290 |
| Stryker | 6 | $256 |
| Johnson & Johnson(2 entities) | 5 | $252 |
| Kls-martin L.p. | 4 | $202 |
| GSK | 7 | $163 |
| Hologic Sales And Service, LLC | 2 | $158 |
| Sanofi | 4 | $110 |
| Checkpoint Surgical, Inc | 1 | $96 |
| Inspire Medical Systems, Inc. | 2 | $53 |
| Regeneron Healthcare Solutions, Inc. | 2 | $46 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $44 |
| UCB, Inc. | 1 | $40 |
| Zimmer Biomet | 2 | $38 |
| Solta Medical, A Division Of Bausch Health US, LLC | 2 | $37 |
| Merck | 1 | $33 |
| Mimedx Group, Inc. | 1 | $27 |
| Integra Lifesciences Corporation | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Smith+Nephew | 1 | $18 |
| Acera Surgical, Inc. | 1 | $15 |
| AstraZeneca | 1 | $14 |
| Aerin Medical Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENDOTINE$12,837
- NA$337
- CoolSeal Generator$142
- TRUMATCH$127
- SMARTLOCK$112
- VSP SYSTEM, VSP CRANIAL$112
- STRAIGHTSHOT$100
How this compares
$22,363 in reported general payments places this provider in the 90th percentile of 257 otolaryngology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XhanceFluticasone Propionate | 22 | $18,674 |
| Azelastine Hcl | 111 | $3,178 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 15 | $1,904 |
| Ipratropium Bromide | 64 | $1,815 |
| Clotrimazole | 49 | $1,233 |
| Fluticasone Propionate | 88 | $1,113 |
| Famotidine | 21 | $346 |
| Omeprazole | 27 | $315 |
| Montelukast Sodium | 26 | $179 |
| Triamcinolone Acetonide | 15 | $35 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Optinose US, Inc.Xhance | $712 | $18,67422 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 257 otolaryngology providers in Michigan.
Other otolaryngology in Dearborn
- Frederick LopatinDearborn$24K
- Ariel WaitzmanDearborn$17K
- Roger TomaDearborn$4K
- Charles BoydBirmingham$825K
- Jack KartushFarmington Hills$225K
- Robert StandringSouthfield$217K
- Robert StachlerWest Bloomfield$174K
- Giancarlo ZulianiBloomfield Hills$61K
- Lamont JonesDetroit$52K
- Gregory WolfAnn Arbor$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.